The search for quality companies, often described as selecting firms with sustainable competitive advantages, is a cornerstone of long-term wealth building. The “Caviar Cruise” strategy, inspired by a methodology from the book of the same name, systematically identifies such companies using quantitative filters. These filters go beyond simple earnings growth, focusing on the durability of profit expansion, capital efficiency, and financial strength. The result is a shortlist of businesses with the potential to compound value for patient, quality-focused investors. One company that consistently surfaces from this screen is Zoetis Inc ( NYSE:ZTS ), a global leader in animal health.
Why Zoetis Passes the Quality Test
The Caviar Cruise screen is built on the premise that true quality is measurable through a combination of consistent growth, high returns on capital, and a strong balance sheet. Zoetis passes these checks with clear, objective data points.
Sustainable and Improving Profitability Growth A core requirement is that a quality company not only grows but does so efficiently. The screen demands a minimum of 5% annual growth in both revenue and EBIT (earnings before interest and taxes) over five years. More importantly, it looks for EBIT growth outpacing revenue growth, a sign that the company is increasing its pricing power or achieving economies of scale. Zoetis’s numbers are a perfect illustration of this principle:
- Revenue growth (5Y CAGR): 5.30% (meets the >5% threshold)
- EBIT growth (5Y CAGR): 9.74% (meets the >5% threshold and, critically, exceeds the revenue growth rate)
This spread of 4.44% shows that Zoetis is converting top-line gains into even faster profit growth, a hallmark of a business with a defensive moat and efficient operations.
Exceptional Return on Invested Capital (ROIC) Perhaps the most vital filter in the Caviar Cruise strategy is a high Return on Invested Capital, which measures how effectively a company turns its investments into profit. The screen uses a strict version, excluding cash, goodwill, and intangibles to get a true picture of operational efficiency. Zoetis’s ROICexgc is an exceptional 40.59% , easily surpassing the screen’s 15% minimum. A return this high implies a strong competitive advantage and the ability to generate significant value from every dollar that is reinvested into the core business.
Solid Financial Health and Cash Conversion A quality company must be financially sturdy. The screen uses two key metrics to assess this:
- Debt to Free Cash Flow (FCF) < 5: Zoetis’s ratio of 3.96 means it could theoretically pay off all its debt using free cash flow in under four years, a comfortable position.
- Profit Quality (5y average) > 75%: This metric measures the conversion of net income into actual free cash flow. Zoetis has a five-year average profit quality of 78.99% , indicating its reported earnings are largely being converted into hard cash, rather than getting tied up in inventory or receivables.
A High-Level View of the Fundamentals
Beyond the specific screen parameters, Zoetis scores a solid 7 out of 10 in our detailed fundamental analysis, which you can explore in detail via the full fundamental analysis report. The score is driven by a top-tier profitability rating (9/10) , supported by an industry-leading Return on Equity (80.25%) and a fat profit margin (28.23%). The company also has an excellent dividend rating (7/10) , supported by a 10-year track record of consistent payments and a very sustainable payout ratio of 33.26%. While its health (6/10) and valuation (6/10) scores are moderate—with a higher-than-average debt-to-equity ratio (2.71) and a P/E ratio (18.31) that is not a deep value—the company’s superior profitability provides a buffer.
Analyst and Market Perspective
The company’s growth story is not just backward-looking. Analysts forecast a continued, albeit more moderate, future revenue growth of 5.30% per year, suggesting the long-term tailwinds of pet humanization and increased protein consumption remain intact. With the S&P 500 exhibiting a positive long-term and short-term trend, a quality compounder like Zoetis fits the profile of a core portfolio holding.
Finding More Quality Candidates
Zoetis is a strong example of what the Caviar Cruise strategy can uncover—a business with high and improving returns, strong cash generation, and a manageable debt load. While it is an interesting candidate, it is just one of several names that pass these rigorous filters. To discover other potential quality investments that meet these same strict criteria, you can run the full Caviar Cruise stock screener for yourself at Chartmill here.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice. You should consult with a qualified financial professional before making any investment decisions. Past performance is not a guarantee of future results.